Antihypertensive mechanism of lactoferrin-derived peptides: Angiotensin receptor blocking effect

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 1, 2014, Pages 173-181

  Fernández Musoles, Ricardo ^a   Castelló Ruiz, María ^b,c,d   Arce, Cristina ^d   Manzanares, Paloma ^a   Ivorra, M Dolores ^d   Salom, Juan B ^b,c,d  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

angiotensin receptor blocker; angiotensin converting enzyme inhibition; antihypertensive mechanism; bovine lactoferrin hydrolysate; lactoferrin derived peptides; renin angiotensin system

Indexed keywords

ANGIOTENSIN RECEPTOR BLOCKER; ANGIOTENSIN-CONVERTING ENZYME; ANTIHYPERTENSIVE EFFECT; BOVINE LACTOFERRIN; INHIBITORY EFFECT; LOW MOLECULAR WEIGHT; RECEPTOR BINDING ASSAYS; RENIN-ANGIOTENSIN SYSTEM; LACTOFERRIN; RENNIN ANGIOTENSIN SYSTEM;

ENZYME INHIBITION; PEPTIDES; PROTEINS;

PEPTIDES; ENZYME INHIBITION;

BOVINAE;

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; LACTOFERRIN; PEPTIDE;

ANIMAL; CHEMISTRY; DRUG EFFECTS; HUMAN; HYPERTENSION; MALE; METABOLISM; MOLECULAR WEIGHT; PATHOPHYSIOLOGY; RABBIT; VASOCONSTRICTION;

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; LACTOFERRIN; MALE; MOLECULAR WEIGHT; PEPTIDES; RABBITS; RECEPTOR, ANGIOTENSIN, TYPE 1; VASOCONSTRICTION;

EID: 84892185184     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf404616f     Document Type: Article

References (51)

1. Ruilope, L. M. Current challenges in the clinical management of hypertension Nat. Rev. Cardiol. 2011, 9, 267-275
2. Roberfroid, M. B. Global view on functional foods: European perspectives Br. J. Nutr. 2002, 88 (Suppl. 8) S133-S138
3. Hartmann, R.; Meisel, H. Food-derived peptides with biological activity: from research to food applications Curr. Opin. Biotechnol. 2007, 18, 163-169
4. Fragasso, G.; Maranta, F.; Montanaro, C.; Salerno, A.; Torlasco, C.; Margonato, A. Pathophysiologic therapeutic targets in hypertension: a cardiological point of view Expert Opin. Ther. Targets 2012, 16, 179-193
5. Hong, F.; Ming, L.; Yi, S.; Zhanxia, L.; Yongquan, W.; Chi, L. The antihypertensive effect of peptides: a novel alternative to drugs? Peptides 2008, 29, 1062-1071
6. Hernández-Ledesma, B.; del Mar Contreras, M.; Recio, I. Antihypertensive peptides: production, bioavailability and incorporation into foods Adv. Colloid Interface Sci. 2011, 165, 23-35
7. González-Chávez, S. A.; Arévalo-Gallegos, S.; Rascón-Cruz, Q. Lactoferrin: structure, function and applications Int. J. Antimicrob. Agents 2009, 33, 301.e1-301.e8
8. Wakabayashi, H.; Takase, M.; Tomita, M. Lactoferricin derived from milk protein lactoferrin Curr. Pharm. Des. 2003, 9, 1277-1287
9. Centeno, J. M.; Burguete, M. C.; Castelló-Ruiz, M.; Enrique, M.; Vallés, S.; Salom, J. B.; Torregrosa, G.; Marcos, J. F.; Alborch, E.; Manzanares, P. Lactoferricin-related peptides with inhibitory effects on ACE-dependent vasoconstriction J. Agric. Food Chem. 2006, 54, 5323-5329
10. Ruiz-Giménez, P.; Ibáñez, A.; Salom, J. B.; Marcos, J. F.; López-Díez, J. J.; Vallés, S.; Torregrosa, G.; Alborch, E.; Manzanares, P. Antihypertensive properties of lactoferricin B-derived peptides J. Agric. Food Chem. 2010, 58, 6721-6727
11. Ruiz-Giménez, P.; Burguete, M. C.; Castello-Ruiz, M.; Marcos, J. F.; Salom, J. B.; Vallés, S.; Torregrosa, G.; Alborch, E.; Manzanares, P. Bovine lactoferrin pepsin hydrolysate exerts inhibitory effect on angiotensin I-converting enzyme-dependent vasoconstriction Int. Dairy J. 2007, 17, 1212-1215
12. Ruiz-Giménez, P.; Salom, J. B.; Marcos, J. F.; Valles, S.; Martínez-Maqueda, D.; Recio, I.; Torregrosa, G.; Alborch, E.; Manzanares, P. Antihypertensive effect of a bovine lactoferrin pepsin hydrolysate: identification of novel active peptides Food Chem. 2012, 131, 266-273
13. Fernández-Musoles, R.; Manzanares, P.; Burguete, M. C.; Alborch, E.; Salom, J. B. In vivo angiotensin I-converting enzyme inhibition by long-term intake of antihypertensive lactoferrin hydrolysate in spontaneously hypertensive rats Food Res. Int. 2013, 54, 627-632
14. Vermeirssen, V.; Van Camp, J.; Verstraete, W. Bioavailability of angiotensin I converting enzyme inhibitory peptides Br. J. Nutr. 2004, 92, 357-366
15. Martínez-Maqueda, D.; Miralles, B.; Recio, I.; Hernández-Ledesma, B. Antihypertensive peptides from food proteins: a review Food Funct. 2012, 3, 350-361
16. Marques, C.; Amorim, M. M.; Pereira, J. O.; Pintado, M. E.; Moura, D.; Calhau, C.; Pinheiro, H. Bioactive peptides: are there more antihypertensive mechanisms beyond ACE inhibition? Curr. Pharm. Des. 2012, 18, 4706-4713
17. Fernández-Musoles, R.; López-Díez, J. J.; Torregrosa, G.; Vallés, S.; Alborch, E.; Manzanares, P.; Salom, J. B. Lactoferricin B-derived peptides with inhibitory effects on ECE-dependent vasoconstriction Peptides 2010, 31, 1926-1933
18. Fernández-Musoles, R.; Salom, J. B.; Martínez-Maqueda, D.; López-Díez, J. J.; Recio, I.; Manzanares, P. Antihypertensive effects of lactoferrin hydrolysates: inhibition of angiotensin- and endothelin-converting enzymes Food Chem. 2013, 139, 994-1000
19. Sentandreu, M. A.; Toldrá, F. A rapid, simple and sensitive fluorescence method for the assay of angiotensin-I converting enzyme Food Chem. 2006, 97, 546-554
20. Faber, J. E.; Yang, N.; Xin, X. Expression of alpha-adrenoceptor subtypes by smooth muscle cells and adventitial fibroblasts in rat aorta and in cell culture J. Pharmacol. Exp. Ther. 2001, 298, 441-452
21. 1 receptor by proanthocyanidins from Guazuma ulmifolia bark Planta Med. 2002, 68, 1066-1071
22. 1 receptor antagonists Bioorg. Med. Chem. 2012, 20, 4208-4216
23. Taylor, A. A.; Siragy, H.; Nesbitt, S. Angiotensin receptor blockers: pharmacology, efficacy, and safety J. Clin. Hypertens. (Greenwich) 2011, 13, 677-686
24. Sica, D. A. Angiotensin receptor blockers: new considerations in their mechanism of action J. Clin. Hypertens. (Greenwich) 2006, 8, 381-385
25. 1-receptor subtype Br. J. Pharmacol. 1993, 110, 761-771
26. Sipola, M.; Finckenberg, P.; Santisteban, J.; Korpela, R.; Vapaatalo, H.; Nurminen, M. L. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats J. Physiol. Pharmacol. 2001, 52, 745-754
27. Vercruysse, L.; Morel, N.; Van Camp, J.; Szust, J.; Smagghe, G. Antihypertensive mechanism of the dipeptide Val-Tyr in rat aorta Peptides 2008, 29, 261-267
28. Ruiz-Giménez, P.; Marcos, J. F.; Torregrosa, G.; Lahoz, A.; Fernández-Musoles, R.; Valles, S.; Alborch, E.; Manzanares, P.; Salom, J. B. Novel antihypertensive hexa- and heptapeptides with ACE-inhibiting properties: from the in vitro ACE assay to the spontaneously hypertensive rat Peptides 2011, 32, 1431-1438
29. Zhang, J.; Villacorta, L.; Chang, L.; Fan, Z.; Hamblin, M.; Zhu, T.; Chen, C. S.; Cole, M. P.; Schopfer, F. J.; Deng, C. X.; Garcia-Barrio, M. T.; Feng, Y. H.; Freeman, B. A.; Chen, Y. E. Nitro-oleic acid inhibits angiotensin II-induced hypertension Circ. Res. 2010, 107, 540-548
30. Poh, T. F.; Ng, H. K.; Hoe, S. Z.; Lam, S. K. Gynura procumbens causes vasodilation by inhibiting angiotensin II and enhancing bradykinin actions J. Cardiovasc. Pharmacol. 2013, 61, 378-384
31. Xue, B.; Li, J.; Chai, Q.; Liu, Z.; Chen, L. Effect of total flavonoid fraction of Astragalus complanatus R. Brown on angiotensin II-induced portal-vein contraction in hypertensive rats Phytomedicine 2008, 15, 759-762
32. Lau, Y. S.; Kwan, C. Y.; Ku, T. C.; Hsieh, W. T.; Wang, H. D.; Nishibe, S.; Dharmani, M.; Mustafa, M. R. Apocynum venetum leaf extract, an antihypertensive herb, inhibits rat aortic contraction induced by angiotensin II: a nitric oxide and superoxide connection J. Ethnopharmacol. 2012, 143, 565-571
33. Kono, R.; Okuno, Y.; Nakamura, M.; Inada, K.; Tokuda, A.; Yamashita, M.; Hidaka, R.; Utsunomiya, H. Peach (Prunus persica) extract inhibits angiotensin II-induced signal transduction in vascular smooth muscle cells Food Chem. 2013, 139, 371-376
34. Guerrero, E. I.; Morán-Pinzón, J. A.; Ortíz, L. G.; Olmedo, D.; del Olmo, E.; López-Pérez, J. L.; San Feliciano, A.; Gupta, M. P. Vasoactive effects of different fractions from two Panamanians plants used in Amerindian traditional medicine J. Ethnopharmacol. 2010, 131, 497-501
35. A receptors: bioactive benzo[c]phenanthridine alkaloids from the root of Bocconia frutescens Planta Med. 2002, 68, 770-775
36. 1 receptor Eur. J. Pharmacol. 2003, 458, 257-262
37. Herichova, I.; Szantoova, K. Renin-angiotensin system: upgrade of recent knowledge and perspectives Endocr. Regul. 2013, 47, 39-52
38. Girgih, A. T.; Udenigwe, C. C.; Abayomi, H. L.; Adebiyi, P.; Aluko, R. E. Kinetics of enzyme inhibition and antihypertensive effects of hemp seed (Cannabis sativa L.) protein hydrolysates J. Am. Oil Chem. Soc. 2011, 88, 1767-1774
39. Udenigwe, C. C.; Lin, Y. S.; Houc, W. C.; Aluko, R. E. Kinetics of the inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions J. Funct. Foods 2009, 1, 199-207
40. Li, H.; Aluko, R. E. Identification and inhibitory properties of multifunctional peptides from pea protein hydrolysate J. Agric. Food Chem. 2010, 58, 11471-11476
41. Fitzgerald, C.; Mora-Soler, L.; Gallagher, E.; O'Connor, P.; Prieto, J.; Soler-Vila, A.; Hayes, M. Isolation and characterization of bioactive pro-peptides with in vitro renin inhibitory activities from the macroalga Palmaria palmata J. Agric. Food Chem. 2012, 60, 7421-7427
42. Schiffrin, E. L. Vascular endothelin in hypertension Vasc. Pharmacol. 2005, 43, 19-29
43. Kedzierski, R. M.; Yanagisawa, M. Endothelin system: the double-edged sword in health and disease Annu. Rev. Pharmacol. Toxicol. 2001, 41, 851-876
44. Foord, S. M.; Bonner, T. I.; Neubig, R. R.; Rosser, E. M.; Pin, J. P.; Davenport, A. P.; Spedding, M.; Harmar, A. J. International Union of Pharmacology. XLVI. G protein-coupled receptor list Pharmacol. Rev. 2005, 57, 279-288
45. A receptor antagonists reduce blood pressure in experimental hypertension J. Pharmacol. Exp. Ther. 2004, 309, 275-284
46. Palmieri, F. E.; Bausback, H. H.; Ward, P. E. Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M Biochem. Pharmacol. 1989, 38, 173-180
47. Ryan, J. W. Peptidase enzymes of the pulmonary vascular surface Am. J. Physiol. 1989, 257, L53-L60
48. Rouissi, N.; Nantel, F.; Drapeau, G.; Rhaleb, N. E.; Dion, S.; Regoli, D. Inhibitors of peptidases: how they influence the biological activities of substance P, neurokinins, kinins and angiotensins in isolated vessels Pharmacology 1990, 40, 185-195
49. Woods, A. S.; Huestis, M. A. A study of peptide-peptide interaction by matrix-assisted laser desorption/ionization J. Am. Soc. Mass Spectrom. 2001, 12, 88-96
50. Foltz, M.; Meynen, E. E.; Bianco, V.; Van Platerink, C.; Koning, T. M.; Kloek, J. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation J. Nutr. 2007, 137, 953-958
51. Van der Pijl, P. C.; Kies, A. K.; Ten Have, G. A.; Duchateau, G. S.; Deutz, N. E. Pharmacokinetics of proline-rich tripeptides in the pig Peptides 2008, 29, 2196-2202